Literature DB >> 14663052

Diagnostic value of sural nerve matrix metalloproteinase-9 in diabetic patients with CIDP.

S Jann1, M A Bramerio, S Beretta, S Koch, C A Defanti, K V Toyka, C Sommer.   

Abstract

Patients with diabetes mellitus (DM) may develop chronic inflammatory demyelinating polyneuropathy (CIDP), which may be difficult to distinguish from diabetic neuropathy (DNP). Here the authors show that immunoreactivity for matrix metalloproteinase-9 on sural nerve biopsies may help to identify CIDP-DM. In a pilot study on 10 CIDP-DM patients with IV immunoglobulins and tight glycemic control, the CIDP-DM patients had a better outcome than DNP patients treated with tight glycemic control only.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14663052     DOI： 10.1212/01.wnl.0000096174.86850.7f

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  11 in total

Review 1.  [Use of i.v. immunoglobulins in neurology. Evidence-based consensus].

Authors:  M Stangel; R Gold
Journal:  Nervenarzt       Date:  2004-08       Impact factor: 1.214

Review 2.  Clinical utility of peripheral nerve biopsy.

Authors:  David Lacomis
Journal:  Curr Neurol Neurosci Rep       Date:  2005-02       Impact factor: 5.081

3.  Peripheral neuropathy induced by administration of cisplatin- and paclitaxel-based chemotherapy. Could it be predicted?

Authors:  Andreas A Argyriou; Panagiotis Polychronopoulos; Angelos Koutras; Gregoris Iconomou; Alexander Iconomou; Haralabos P Kalofonos; Elisabeth Chroni
Journal:  Support Care Cancer       Date:  2005-02-15       Impact factor: 3.603

Review 4.  Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Association With Concomitant Diseases: Identification and Management.

Authors:  Yan Chen; Xiangqi Tang
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

5.  Treatment-Induced Neuropathy in Diabetes (TIND)-Developing a Disease Model in Type 1 Diabetic Rats.

Authors:  Petra Baum; Severin Koj; Nora Klöting; Matthias Blüher; Joseph Classen; Sabine Paeschke; Martin Gericke; Klaus V Toyka; Marcin Nowicki; Joanna Kosacka
Journal:  Int J Mol Sci       Date:  2021-02-04       Impact factor: 5.923

6.  Dysregulated IGFBP5 expression causes axon degeneration and motoneuron loss in diabetic neuropathy.

Authors:  Christian M Simon; Stefanie Rauskolb; Jennifer M Gunnersen; Bettina Holtmann; Carsten Drepper; Benjamin Dombert; Massimiliano Braga; Stefan Wiese; Sibylle Jablonka; Dirk Pühringer; Jürgen Zielasek; Andreas Hoeflich; Vincenzo Silani; Eckhard Wolf; Susanne Kneitz; Claudia Sommer; Klaus V Toyka; Michael Sendtner
Journal:  Acta Neuropathol       Date:  2015-05-30       Impact factor: 17.088

Review 7.  Chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus.

Authors:  Farzad Fatehi; Shahriar Nafissi; Keivan Basiri; Mostafa Amiri; Akbar Soltanzadeh
Journal:  J Res Med Sci       Date:  2013-05       Impact factor: 1.852

Review 8.  The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy.

Authors:  Vera Bril; Christopher M Blanchette; Joshua M Noone; M Chris Runken; Deborah Gelinas; James W Russell
Journal:  J Diabetes Complications       Date:  2016-05-10       Impact factor: 2.852

9.  Corneal confocal microscopy differentiates inflammatory from diabetic neuropathy.

Authors:  Michael Fleischer; Inn Lee; Friedrich Erdlenbruch; Lena Hinrichs; Ioannis N Petropoulos; Rayaz A Malik; Hans-Peter Hartung; Bernd C Kieseier; Christoph Kleinschnitz; Mark Stettner
Journal:  J Neuroinflammation       Date:  2021-04-08       Impact factor: 8.322

10.  The characteristics of chronic inflammatory demyelinating polyneuropathy in patients with and without diabetes--an observational study.

Authors:  Samantha K Dunnigan; Hamid Ebadi; Ari Breiner; Hans D Katzberg; Carolina Barnett; Bruce A Perkins; Vera Bril
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.